📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. (2015)

First Author: Boulter L

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci76452

PubMed Identifier: 25689248

Publication URI: http://europepmc.org/abstract/MED/25689248

Type: Journal Article/Review

Volume: 125

Parent Publication: The Journal of clinical investigation

Issue: 3

ISSN: 0021-9738